1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with dinoprost in 43 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (dinoprost) | Trials (dinoprost) | Recent Studies (post-2010) (dinoprost) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 11,554 | 940 | 1,936 |
| Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | dinoprost (IC50) |
|---|---|---|---|
| Prostaglandin G/H synthase 1 | Bos taurus (cattle) | 0.0025 | |
| Prostaglandin G/H synthase 2 | Bos taurus (cattle) | 0.0713 | |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 0.14 | |
| Prostaglandin E2 receptor EP1 subtype | Homo sapiens (human) | 0.3 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.14 | |
| Prostaglandin E2 receptor EP4 subtype | Homo sapiens (human) | 4.2 | |
| Prostaglandin F2-alpha receptor | Bos taurus (cattle) | 0.14 | |
| Prostaglandin F2-alpha receptor | Homo sapiens (human) | 0.0139 | |
| Prostaglandin E2 receptor EP3 subtype | Homo sapiens (human) | 0.216 | |
| Prostaglandin D2 receptor | Homo sapiens (human) | 4.5 | |
| Solute carrier organic anion transporter family member 2B1 | Rattus norvegicus (Norway rat) | 0.287 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (32.56) | 18.7374 |
| 1990's | 20 (46.51) | 18.2507 |
| 2000's | 7 (16.28) | 29.6817 |
| 2010's | 2 (4.65) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Battye, KM; Evans, G; O'Neill, C | 2 |
| Chaussade, S; Denizot, Y | 1 |
| Braquet, P; Filep, JG; Mózes, T | 1 |
| Benedetto, C; Hammerstein, J; Leo-Rossberg, I; Lübbert, H; Nigam, S; Zonca, M | 1 |
| Chilton, FH; Churchill, L; Proud, D | 1 |
| Stewart, HJ | 1 |
| Gimbrone, MA; Hrbolich, JK; Schafer, AI; Zavoico, GB | 1 |
| Badr, KF; Blair, I; Christman, BW; Schreiner, GF; Takahashi, K; Yamashita, K | 1 |
| Keery, RJ; Lumley, P | 1 |
| Kasai, H; Matsui, S; Ninomiya, K; Yanagihara, Y | 1 |
| Mitchell, MD; Weinreb, RN | 1 |
| Emery, D; Margolskee, D; Nadel, JA; Ueki, IF; Widdicombe, JH; Yergey, J | 1 |
| Ludwig, H | 1 |
| Armstead, WM; Busija, DW; Leffler, CW; Mirro, R | 1 |
| Dinya, Z; Farkas, T; Gergely, P; Sipka, S; Szegedi, G | 1 |
| O'Flaherty, JT; Rossi, AG | 1 |
| Armstrong, RA; Jones, RL; Wilson, NH | 1 |
| Altin, JG; Bygrave, FL | 1 |
| Becker, K; Förster, W | 1 |
| Kelly, RW; Smith, SK | 1 |
| Houston, DS; Vanhoutte, PM | 1 |
| Blank, ML; Feuerstein, G; Kopin, IJ; Krausz, MM; Snyder, F; Zukowska-Grojec, Z | 1 |
| Fortier, MA; Kim, JJ | 1 |
| Goff, AK; Slama, H; Vaillancourt, D | 2 |
| Dahms, TE; Ohar, JA; Waller, KS | 1 |
| Chen, BN; McLoughlin, JW; Menadue, MF; Norman, RJ; Oliver, JR; Rayner, TE | 1 |
| Bartula, L; Kadesky, K; Kalley-Taylor, B; Myers, SI; Riva, A; Turnage, R | 1 |
| French, JT; French, LN; Harms, PG; Randel, RD; Sasser, RG; Weems, CW; Weems, YS; Welsh, TH | 1 |
| Hertelendy, F; Molnár, M; Rigó, J | 1 |
| Egashira, K; Fukumoto, Y; Kadokami, T; Katsumata, N; Kozai, T; Kuwata, K; Shimokawa, H; Takeshita, A; Yamawaki, T | 1 |
| Bazer, F; Chami, O; Megevand, A; O'Neill, C; Ott, T | 1 |
| Aimbire, F; Cailleaux, S; Cordeiro, RS; Lopes-Martins, RA; Tibiriçá, E | 1 |
| Chami, O; Evans, G; O'Neill, C | 1 |
| Azuma, J; Fujio, Y; Fujitsu, J; Kasayama, S; Kim, J; Maeda, M; Sumita, C; Yamamoto, I | 1 |
| Atilla, G; Başkesen, A; Berdeli, AH; Buduneli, E; Buduneli, N; Türkoğlu, O; Vardar, S | 1 |
| Atilla, G; Başkesen, A; Baylas, H; Berdeli, AH; Buduneli, E; Türkoğlu, O; Vardar, S | 1 |
| Atilla, G; Baylas, H; Berdeli, AH; Buduneli, E; Buduneli, N; Vardar, S | 1 |
| Behar, J; Biancani, P; Cao, W; Cheng, L; Fiocchi, C; Harnett, KM; Liu, F | 1 |
| Aoki, J; Arai, H; Inoue, T; Itabe, H; Kono, N; Matsusue, T; Niki, E; Sato, H; Yoshida, Y | 1 |
| Han, A; Hellman, KM; Jilling, T; Oladosu, FA; Prasad, PV; Segel, C; Tu, FF; Yu, PY | 1 |
| Hao, TT; Huang, TT; Li, JM; Lin, CR; Liu, JX; Ren, JG; Ren, JX; Shi, YH; Wang, M | 1 |
4 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and dinoprost
| Article | Year |
|---|---|
[Mediators of inflammation and hemorrhagic rectocolitis].
Topics: Arachidonic Acids; Colitis, Ulcerative; Dinoprost; Dinoprostone; Eicosanoids; Gastrointestinal Motility; Humans; Leukotriene B4; Platelet Activating Factor | 1991 |
Trophoblastic factors and the maternal recognition of pregnancy in sheep and cattle.
Topics: Amino Acid Sequence; Animals; Cattle; Corpus Luteum Maintenance; Dinoprost; Female; Interferon Type I; Luteolytic Agents; Molecular Sequence Data; Oxytocin; Platelet Activating Factor; Pregnancy; Pregnancy Proteins; Pregnancy, Animal; Progesterone; Sequence Homology, Nucleic Acid; Sheep; Trophoblasts | 1990 |
[The chorion and decidua--morphology and biomolecular processes for their activation exemplified by premature rupture of the fetal membranes].
Topics: Arachidonic Acid; Arachidonic Acids; Chorion; Decidua; Dinoprost; Female; Fetal Membranes, Premature Rupture; Humans; Immunohistochemistry; Infant, Newborn; Interleukin-1; Platelet Activating Factor; Pregnancy; Uterine Contraction | 1989 |
Effect of histone-H2A (H-H2A), platelet activating factor (PAF) and pregnancy specific protein B (PSPB) on secretion of prostaglandins E and F2 alpha (PGE; PGF2 alpha) by bovine endometrium and H-H2A on basal secretion of luteinizing hormone (LH) by bovin
Topics: Animals; Aspartic Acid Endopeptidases; Cattle; Dinoprost; Endometrium; Female; Histones; Luteinizing Hormone; Pituitary Gland; Platelet Activating Factor; Pregnancy Proteins; Prostaglandins; Prostaglandins E | 1996 |
39 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and dinoprost
| Article | Year |
|---|---|
Evidence that platelet-activating factor suppresses uterine oxytocin-induced 13,14-dihydro-15-keto-prostaglandin F2 alpha release and phosphatidylinositol hydrolysis in the ewe.
Topics: Animals; Dinoprost; Endometrium; Female; Hydrolysis; Injections; Inositol; Inositol Phosphates; Ovariectomy; Oxytocin; Phosphatidylinositols; Platelet Activating Factor; Radioimmunoassay; Second Messenger Systems; Sheep; Tritium; Uterus | 1992 |
Interactions between platelet-activating factor and prostanoids during mesenteric ischemia-reperfusion-induced shock in the anesthetized dog.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Dinoprost; Diterpenes; Dogs; Ginkgolides; Hemodynamics; Indomethacin; Lactones; Male; Mesenteric Arteries; Mesenteric Veins; Platelet Activating Factor; Prostaglandins; Reperfusion Injury; Shock; Thromboxane B2 | 1991 |
Increased concentrations of eicosanoids and platelet-activating factor in menstrual blood from women with primary dysmenorrhea.
Topics: Adult; Dinoprost; Dinoprostone; Dysmenorrhea; Female; Humans; Menstrual Cycle; Platelet Activating Factor; SRS-A | 1991 |
Interaction of platelet-activating factor with cultured guinea pig tracheal epithelial cells.
Topics: Animals; Cells, Cultured; Dinoprost; Epithelium; Guinea Pigs; Male; Platelet Activating Factor; Trachea | 1991 |
Enhancement of thrombin- and ionomycin-stimulated prostacyclin and platelet-activating factor production in cultured endothelial cells by a tumor-promoting phorbol ester.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Alkaloids; Arachidonic Acids; Calcimycin; Cells, Cultured; Dinoprost; Dinoprostone; Endothelium, Vascular; Epoprostenol; Humans; Ionomycin; Isoquinolines; Phorbol Esters; Phospholipases A; Phospholipases A2; Piperazines; Platelet Activating Factor; Prostaglandin D2; Prostaglandins H; Protein Kinase C; Staurosporine; Tetradecanoylphorbol Acetate; Thrombin | 1990 |
Predominant functional roles for thromboxane A2 and prostaglandin E2 during late nephrotoxic serum glomerulonephritis in the rat.
Topics: Animals; Blood Pressure; Dinoprost; Dinoprostone; Glomerular Filtration Rate; Glomerulonephritis; Hematocrit; Male; Platelet Activating Factor; Proteinuria; Rats; Thromboxane A2; Vascular Resistance | 1990 |
AH6809, a prostaglandin DP-receptor blocking drug on human platelets.
Topics: 1-Methyl-3-isobutylxanthine; 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine; Adenosine Diphosphate; Adenosine-5'-(N-ethylcarboxamide); Dinoprost; Epoprostenol; Humans; Hydantoins; In Vitro Techniques; Male; Platelet Activating Factor; Platelet Aggregation; Prostaglandin D2; Prostaglandin Endoperoxides, Synthetic; Receptors, Immunologic; Receptors, Prostaglandin; Xanthenes; Xanthones | 1988 |
Immunopharmacological studies on TBX, a new antiallergic drug (3). Inhibitory effects on histamine release from lung fragments and bronchoconstriction in guinea pigs.
Topics: Animals; Asthma; Bronchi; Dinoprost; Guinea Pigs; Histamine Antagonists; Histamine Release; In Vitro Techniques; Lung; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Platelet Activating Factor; Platelet Aggregation; Pyridines; Pyrimidinones; SRS-A; Trachea | 1989 |
Prostaglandin production by cultured cynomolgus monkey trabecular meshwork cells.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Bradykinin; Calcimycin; Cells, Cultured; Dexamethasone; Dinoprost; Dinoprostone; Humans; Macaca fascicularis; Platelet Activating Factor; Prostaglandins; Radioimmunoassay; Trabecular Meshwork | 1989 |
Release of cyclooxygenase products from primary cultures of tracheal epithelia of dog and human.
Topics: Animals; Bradykinin; Calcimycin; Cells, Cultured; Dinoprost; Dinoprostone; Dogs; Epithelium; Gas Chromatography-Mass Spectrometry; Humans; Isoproterenol; Kinetics; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Species Specificity; SRS-A; Thromboxane B2; Trachea | 1989 |
Permissive role of prostanoids in acetylcholine-induced cerebral vasoconstriction.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Animals; Bridged Bicyclo Compounds, Heterocyclic; Cerebrovascular Circulation; Dinoprost; Fatty Acids, Unsaturated; Female; Hydrazines; Male; Platelet Activating Factor; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandins H; Receptors, Prostaglandin; Receptors, Thromboxane; Receptors, Thromboxane A2, Prostaglandin H2; Swine; Vasoconstriction | 1989 |
Simultaneous presence of platelet activating factor, leukotriene B4, prostaglandin F1 alpha and F2 alpha in the supernatant of human neutrophils treated with phospholipase A2 of human monocytes.
Topics: Dinoprost; Humans; Leukotriene B4; Molecular Weight; Monocytes; Neutrophils; Phospholipases; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Prostaglandins F | 1989 |
Prostaglandin binding sites in human polymorphonuclear neutrophils.
Topics: Dinoprost; Dinoprostone; Humans; Leukotriene B4; Neutrophils; Platelet Activating Factor; Prostaglandin D2; Prostaglandins; Receptors, Prostaglandin | 1989 |
Mechanism of the inhibition of platelet aggregation produced by prostaglandin F2 alpha.
Topics: Adenosine Diphosphate; Aspirin; Cyclic AMP; Cyclic GMP; Dinoprost; Humans; Platelet Activating Factor; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandins F; Prostaglandins H; Prostaglandins, Synthetic; Thrombin | 1985 |
Prostaglandin F2 alpha and the thromboxane A2 analogue ONO-11113 stimulate Ca2+ fluxes and other physiological responses in rat liver. Further evidence that prostanoids may be involved in the action of arachidonic acid and platelet-activating factor.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Calcium; Dinoprost; Dinoprostone; Glucagon; In Vitro Techniques; Liver; Male; Oxygen Consumption; Phenylephrine; Platelet Activating Factor; Prostaglandin D2; Prostaglandins D; Prostaglandins E; Prostaglandins F; Rats; Rats, Inbred Strains; Thromboxane A2; Vasoconstriction | 1988 |
Influence of prostaglandins and PG-analogues on the mortality of PAF-acether in mice and the TXB2 release from human granulocytes.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Dinoprost; Granulocytes; Humans; In Vitro Techniques; Mice; Mice, Inbred Strains; Platelet Activating Factor; Prostaglandins; Prostaglandins, Synthetic; Skin; Species Specificity; Thromboxane B2 | 1988 |
Effect of platelet-activating factor on the release of PGF-2 alpha and PGE-2 by separated cells of human endometrium.
Topics: Cells, Cultured; Dinoprost; Dinoprostone; Dose-Response Relationship, Drug; Endometrium; Female; Humans; Platelet Activating Factor; Prostaglandins E; Prostaglandins F | 1988 |
Platelets, endothelium, and vasospasm.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Dinoprost; Endothelium; Humans; Platelet Activating Factor; Platelet Aggregation; Prostaglandins F; Serotonin; Thromboxanes; Vasoconstriction | 1985 |
Cardiovascular and sympathetic effects of l-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine in conscious SHR and WKY rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Dinoprost; Epinephrine; Heart Rate; Hemodynamics; Male; Norepinephrine; Platelet Activating Factor; Prostaglandins F; Rats; Rats, Inbred Strains; Sympathetic Nervous System; Thromboxane B2 | 1982 |
Cell type specificity and protein kinase C dependency on the stimulation of prostaglandin E2 and prostaglandin F2 alpha production by oxytocin and platelet-activating factor in bovine endometrial cells.
Topics: Animals; Cattle; Cells, Cultured; Dinoprost; Dinoprostone; Endometrium; Female; Oxytocin; Platelet Activating Factor; Prostaglandins; Protein Kinase C; Stimulation, Chemical; Tachyphylaxis; Tetradecanoylphorbol Acetate; Time Factors | 1995 |
Control of in vitro prostaglandin F2 alpha and E2 synthesis by caruncular and allantochorionic tissues from cows that calved normally and those with retained fetal membranes.
Topics: Allantois; Animals; Calcium; Cattle; Cattle Diseases; Chorion; Culture Techniques; Dinoprost; Dinoprostone; Epidermal Growth Factor; Estradiol; Extraembryonic Membranes; Female; Labor Stage, Third; Obstetric Labor Complications; Oxytocin; Placenta; Platelet Activating Factor; Pregnancy; Protein Kinase C | 1994 |
Platelet-activating factor induces selective pulmonary arterial hyperreactivity in isolated perfused rabbit lungs.
Topics: Angiotensin II; Animals; Dinoprost; Female; In Vitro Techniques; Norepinephrine; Perfusion; Platelet Activating Factor; Potassium Chloride; Pulmonary Artery; Pulmonary Circulation; Rabbits; Regression Analysis; Time Factors; Vascular Resistance | 1993 |
Prostaglandin F2 alpha mediates platelet-activating factor-stimulated atrial natriuretic factor release from the isolated rat heart.
Topics: Animals; Atrial Natriuretic Factor; Dinoprost; Dinoprostone; Heart; Heart Rate; Indomethacin; Kinetics; Male; Meclofenamic Acid; Myocardial Contraction; Perfusion; Platelet Activating Factor; Prostaglandins E; Prostaglandins F; Rats | 1993 |
Metabolism of arachidonic acid by caruncular and allantochorionic tissues in cows with retained fetal membranes (RFM).
Topics: 6-Ketoprostaglandin F1 alpha; Allantois; Animals; Arachidonic Acid; Calcium; Cattle; Chorion; Chromatography, High Pressure Liquid; Dinoprost; Dinoprostone; Epidermal Growth Factor; Female; Hydroxyeicosatetraenoic Acids; Leukotriene B4; Oxytocin; Placenta; Placenta Diseases; Platelet Activating Factor; Pregnancy; Thromboxane B2 | 1993 |
Platelet activating factor (PAF) stimulates release of PGI2 from inflamed rabbit gallbladder cell cultures.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Antibodies; Cells, Cultured; Cholecystitis; Cytochrome P-450 Enzyme System; Dinoprost; Dose-Response Relationship, Drug; Epoprostenol; Gallbladder; Immunoblotting; Indomethacin; Intramolecular Oxidoreductases; Isomerases; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Proteins; Rabbits; Thromboxane B2 | 1995 |
Ovine endometrium synthesizes and releases platelet-activating factor, which can cause the release of prostaglandin F2 alpha by the uterus in situ.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Acetyltransferases; Animals; Dinoprost; Endometrium; Estrogen Replacement Therapy; Female; Kinetics; Ovariectomy; Oxytocin; Phospholipases A; Platelet Activating Factor; Sheep; Uterus | 1996 |
Signal transduction in human myometrial cells.
Topics: Calcium; Cell Membrane Permeability; Cells, Cultured; Dinoprost; Female; Humans; Inositol 1,4,5-Trisphosphate; Kinetics; Muscle, Smooth; Myometrium; Oxytocin; Phosphatidylinositols; Platelet Activating Factor; Signal Transduction | 1996 |
Platelet activating factor causes hyperconstriction at the inflammatory coronary lesions in pigs in vivo.
Topics: Animals; Coronary Vasospasm; Coronary Vessels; Dinoprost; Drug Synergism; Histamine; Interleukin-1; Isoquinolines; Male; Platelet Activating Factor; Platelet Aggregation Inhibitors; Protein Kinase C; Pyridinium Compounds; Serotonin; Swine; Tetrahydroisoquinolines; Vasoconstriction | 1997 |
Platelet-activating factor may act as an endogenous pulse generator for sheep of luteolytic PGF2alpha release.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Dinoprost; Endometrium; Estradiol; Estrus; Female; Hemolysis; Interferon-gamma; Organ Culture Techniques; Ovariectomy; Phospholipases A; Platelet Activating Factor; Pregnancy; Progesterone; Recombinant Proteins; Sheep; Uterus | 1999 |
Involvement of platelet-activating factor in the modulation of vascular tone in the isolated perfused rabbit kidney.
Topics: Animals; Azepines; Dinoprost; Enzyme Inhibitors; Female; Furans; In Vitro Techniques; Kidney; Lignans; Male; Muscle Tonus; Muscle, Smooth, Vascular; Norepinephrine; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Platelet Aggregation Inhibitors; Quinacrine; Rabbits; Renal Circulation; Triazoles; Vasoconstrictor Agents | 1999 |
Components of a platelet-activating factor-signaling loop are assembled in the ovine endometrium late in the estrous cycle.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Corpus Luteum; Dinoprost; Endometrium; Estradiol; Estrous Cycle; Female; Ovariectomy; Platelet Activating Factor; Platelet Membrane Glycoproteins; Progesterone; Receptors, G-Protein-Coupled; RNA, Messenger; Sheep; Signal Transduction | 2004 |
Pioglitazone induces plasma platelet activating factor-acetylhydrolase and inhibits platelet activating factor-mediated cytoskeletal reorganization in macrophage.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Cell Line; Cytoskeleton; Dinoprost; Enzyme Induction; Humans; Macrophages; Pioglitazone; Platelet Activating Factor; Receptors, Cytoplasmic and Nuclear; Thiazolidinediones; Transcription Factors | 2004 |
Effects of combined systemic administration of low-dose doxycycline and alendronate on endotoxin-induced periodontitis in rats.
Topics: Alendronate; Alveolar Bone Loss; Animals; Anti-Bacterial Agents; Dinoprost; Dinoprostone; Doxycycline; Drug Therapy, Combination; Endotoxins; Gingiva; Leukotriene B4; Male; Periodontitis; Platelet Activating Factor; Rats; Rats, Sprague-Dawley | 2004 |
Therapeutic versus prophylactic plus therapeutic administration of omega-3 fatty acid on endotoxin-induced periodontitis in rats.
Topics: Alveolar Bone Loss; Analysis of Variance; Animals; Dinoprost; Dinoprostone; Endotoxins; Fatty Acids, Omega-3; Gingiva; Immunoenzyme Techniques; Inflammation Mediators; Leukotriene B4; Male; Periodontitis; Platelet Activating Factor; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Statistics, Nonparametric | 2004 |
Individual and combined effects of selective cyclooxygenase-2 inhibitor and omega-3 fatty acid on endotoxin-induced periodontitis in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase Inhibitors; Dinoprost; Dinoprostone; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Endotoxins; Fatty Acids, Omega-3; Leukotriene B4; Male; Periodontitis; Platelet Activating Factor; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides | 2005 |
Hydrogen peroxide reduces lower esophageal sphincter tone in human esophagitis.
Topics: Dinoprost; Esophageal Sphincter, Lower; Esophagitis, Peptic; F2-Isoprostanes; Gene Expression Regulation, Enzymologic; Humans; Hydrogen Peroxide; In Vitro Techniques; Inflammation Mediators; Muscle Tonus; NADPH Oxidases; Oxidants; Oxygen; Platelet Activating Factor; Signal Transduction | 2005 |
Protection against oxidative stress-induced hepatic injury by intracellular type II platelet-activating factor acetylhydrolase by metabolism of oxidized phospholipids in vivo.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Carbon Tetrachloride; Dinoprost; Embryo, Mammalian; Epithelium; Esterification; Fibroblasts; Gene Targeting; Hydrolysis; Liver; Macrophages, Peritoneal; Mice; Mice, Knockout; Oxidation-Reduction; Oxidative Stress; Phospholipids; Platelet Activating Factor; tert-Butyl Alcohol | 2008 |
The Effects of Platelet-Activating Factor on Uterine Contractility, Perfusion, Hypoxia, and Pain in Mice.
Topics: Animals; Dinoprost; Female; Hyperalgesia; Hypoxia; Mice; Mice, Knockout; Oxytocin; Perfusion; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Uterine Contraction; Uterus; Visceral Pain | 2018 |
[Effects of sleep deprivation induced blood stasis syndrome on platelet activation in rats].
Topics: Animals; Dinoprost; Disease Models, Animal; Hemorheology; Medicine, Chinese Traditional; Platelet Activating Factor; Platelet Activation; Rats; Sleep Deprivation; T-Box Domain Proteins; Thrombosis | 2018 |